Richard L. Lindstrom M.D., Director at HARROW HEALTH, INC. (HROW), sold 3,900 shares at $10.04 ($39K) on 2021-09-24, disclosed to the SEC on 2021-09-27.
Scheduled sale ($39k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HROW | SELL | 2022-10-03 | $1.0M | — | Filing → |
| HROW | SELL | 2021-09-17 | $363K | — | Filing → |
| HROW | SELL | 2021-05-21 | $108K | — | Filing → |